Calidi Biotherapeutics, Inc.
Develops immunotherapies using stem cells to deliver oncolytic viruses against solid tumors.
CLDI | NYSE
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 4475 EXECUTIVE DRIVE, 92121 SAN DIEGO
- Website:
- https://www.calidibio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Calidi Biotherapeutics, Inc. is a clinical-stage immuno-oncology company developing novel immunotherapies to combat cancer. The company's proprietary technology utilizes "off-the-shelf" allogeneic stem cells to deliver and shield oncolytic viral payloads from the patient's immune system. This approach is designed to enable the therapy to effectively reach and destroy solid tumors locally while simultaneously stimulating a systemic anti-tumor immune response to target metastatic disease. Calidi's platforms aim to transform immunologically "cold" tumors into "hot" tumors, making them recognizable for attack by the immune system. Its pipeline includes CLD-201 (SuperNova), which received FDA Fast Track Designation for soft tissue sarcoma, and the RedTail platform for systemic delivery of genetic medicine.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Calidi Biotherapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Calidi Biotherapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Calidi Biotherapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
